Dexcom (Nasdaq:DXCM) shares are up today — a day after it reported third-quarter results that came in ahead of the consensus forecast. DXCM shares were up more than 17% at $118.78 by the afternoon today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down more than 1%. The San […]
Bio-Rad stock dips as COVID-19-related sales taper off in Q3
Bio-Rad (NYSE:BIO) shares took a hit on third-quarter results that came in mixed compared to the consensus forecast. BIO shares were down more than 6% at $359.75 apiece this morning — a day after the company released its results. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down […]
Neocis raises $40M for dental surgical robot
Robot-assisted dental surgery technology developer Neocis announced today that it completed an oversubscribed financing round worth $40 million. Miami-based Neocis manufactures Yomi, a computerized robotic navigational system. It provides assistance in the preoperative and intraoperative phases of dental implantation surgery. Yomi provides software for planning procedures and offers robotic navigational guidance for surgical instruments during […]
Better Therapeutics names new chief commercial officer
Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Diane Gomez-Thinnes as its new chief commercial officer (CCO). Gomez-Thinnes’ appointment became effective yesterday, Oct. 26, 2022. She joins the San Francisco-based company, which develops prescription digital therapeutics (PDTs). They use a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, […]
Synchron to begin enrollment at UPMC for brain-computer interface trial
Synchron announced today that it started enrollment in the Command trial for its brain-computer interface (BCI) technology. The company commenced enrollment at the University of Pittsburgh in Pittsburgh, Pennsylvania. It plans for its early feasibility study to primarily assess safety while exploring quantified efficacy measures of the Synchron Stentrode. Synchron’s study, funded by the National […]
Align Technology stock sinks on Q3 sales, EPS misses
Align Technology (Nasdaq:ALGN) shares took a massive hit today — a day after it reported Q3 results well short of the consensus forecast. ALGN shares fell 15.9% to $186.35 apiece in mid-morning trading. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 1.3%. The Tempe, Arizona-based dental […]
Conmed stock slides on Q3 revenue miss, slashed EPS guidance
Conmed (NYSE:CNMD) shares took a hit today on third-quarter results that missed the consensus revenue forecast. CNMD shares fell 7.8% to $77.15 apiece in morning trading. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up more than 1%. Despite the revenue miss and EPS guidance cut, […]
Novocure beats The Street in Q3
Novocure (Nasdaq:NVCR) shares rose slightly today on third-quarter results that came in ahead of the consensus forecast. The St. Helier, Jersey–based tumor-treating fields developer posted losses of $26.6 million for the quarter. That amounts to losses of 25¢ per share on sales of $131 million for the three months ended Sept. 30, 2022. Novocure registered […]
Merit Medical rises on Street-beating Q3, raised guidance
Merit Medical Systems (Nasdaq:MMSI) shares are up today — a day after it reported Q3 results that topped the consensus forecast. The South Jordan, Utah-based disposable medical device maker announced yesterday evening that it posted profits of $15.3 million in the quarter. That amounts to 27¢ per share. Merit registered sales of $287.2 million for […]
Olympus’ Evident opens new Asia-Pacific HQ
Olympus‘ Evident announced that it opened its new Asia-Pacific headquarters in Singapore as it looks to expand in the APAC region. In April, Olympus completed the separation of its Scientific Solutions Division into a wholly-owned subsidiary called Evident. The move aimed to provide more room to focus on the continued growth of the company’s Medical […]
EndoStim wins FDA breakthrough designation for EndoStim to treat drug-refractory GERD
EndoStim announced that it received FDA breakthrough device designation for its neurostimulation system for treating GERD. Santa Ana, California-based EndoStim designed its system to treat drug-refractory gastroesophageal reflux disease (GERD). The disease affects the ring of muscle between the esophagus and the stomach, the lower esophageal sphincter (LES). It causes stomach acid to repeatedly flow […]